Total Payments
$11,080
2024 Payments
$337.43
Companies
22
Transactions
79
Medicare Patients
3,541
Medicare Billing
$225,816
Payment Breakdown by Category
Other$6,500 (58.7%)
Food & Beverage$2,614 (23.6%)
Travel$1,965 (17.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $6,500 | 1 | 58.7% |
| Food and Beverage | $2,614 | 70 | 23.6% |
| Travel and Lodging | $1,965 | 8 | 17.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $9,303 | 27 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $561.66 | 9 | $0 (2023) |
| Boston Scientific Corporation | $271.34 | 3 | $0 (2024) |
| Cardiovascular Systems Inc. | $188.98 | 4 | $0 (2020) |
| Edwards Lifesciences Corporation | $111.67 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $108.21 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $83.15 | 6 | $0 (2023) |
| La Jolla Pharmaceutical Company | $58.47 | 1 | $0 (2021) |
| Amgen Inc. | $53.37 | 3 | $0 (2024) |
| Abbott Laboratories | $47.48 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $337.43 | 9 | Boston Scientific Corporation ($192.65) |
| 2023 | $180.65 | 10 | Novartis Pharmaceuticals Corporation ($43.97) |
| 2022 | $197.94 | 9 | Boston Scientific Corporation ($78.69) |
| 2021 | $98.24 | 4 | La Jolla Pharmaceutical Company ($58.47) |
| 2020 | $2,050 | 17 | Medtronic Vascular, Inc. ($1,869) |
| 2019 | $6,971 | 15 | Medtronic Vascular, Inc. ($6,549) |
| 2018 | $1,110 | 12 | Medtronic Vascular, Inc. ($885.10) |
| 2017 | $134.54 | 3 | Janssen Pharmaceuticals, Inc ($98.64) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $24.53 | General |
| Category: Medical Device | ||||||
| 09/04/2024 | Boston Scientific Corporation | Stingray (Device) | Food and Beverage | In-kind items and services | $77.43 | General |
| Category: Stingray_IC | ||||||
| 05/17/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $115.22 | General |
| Category: AVVIGO_IC | ||||||
| 04/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.54 | General |
| Category: Cardiovascular | ||||||
| 01/25/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 01/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Cardiology | ||||||
| 11/10/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/01/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/11/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/15/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/12/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Heart Failure | ||||||
| 04/13/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $13.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/23/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/08/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/29/2022 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/20/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.36 | General |
| Category: Cardiovascular | ||||||
| 09/27/2022 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardiology | ||||||
| 09/23/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,040 | 1,167 | $230,757 | $64,636 |
| 2022 | 20 | 1,066 | 1,178 | $234,530 | $70,955 |
| 2021 | 16 | 1,131 | 1,290 | $226,170 | $72,501 |
| 2020 | 8 | 304 | 338 | $51,380 | $17,725 |
Total Patients
3,541
Total Services
3,973
Medicare Billing
$225,816
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 48 | 49 | $76,440 | $10,006 | 13.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 183 | 184 | $55,200 | $9,429 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 83 | $15,770 | $7,311 | 46.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 67 | 69 | $14,490 | $6,934 | 47.9% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 13 | 14 | $12,880 | $6,106 | 47.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 65 | 87 | $10,005 | $5,369 | 53.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $9,500 | $4,584 | 48.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 78 | $10,530 | $4,572 | 43.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 32 | $9,760 | $4,253 | 43.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 219 | 280 | $4,200 | $1,642 | 39.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 23 | 26 | $1,872 | $1,011 | 54.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 84 | 85 | $2,125 | $916.32 | 43.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 38 | 39 | $4,135 | $731.88 | 17.7% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 11 | 11 | $1,650 | $723.59 | 43.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 68 | 74 | $1,480 | $720.52 | 48.7% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 18 | 18 | $720.00 | $327.96 | 45.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 180 | 180 | $54,000 | $9,555 | 17.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 42 | 44 | $68,640 | $9,404 | 13.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 53 | 54 | $16,470 | $8,221 | 49.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 62 | $11,780 | $5,670 | 48.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 11 | 11 | $10,120 | $5,012 | 49.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 67 | 88 | $9,680 | $4,876 | 50.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 42 | 42 | $9,000 | $4,468 | 49.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 38 | 51 | $8,160 | $4,066 | 49.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $7,260 | $3,306 | 45.5% |
About Andrew Stiff
Andrew Stiff is a Cardiovascular Disease healthcare provider based in Lancaster, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2012. The National Provider Identifier (NPI) number assigned to this provider is 1053687525.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Andrew Stiff has received a total of $11,080 in payments from pharmaceutical and medical device companies, with $337.43 received in 2024. These payments were reported across 79 transactions from 22 companies. The most common payment nature is "Grant" ($6,500).
As a Medicare-enrolled provider, Stiff has provided services to 3,541 Medicare beneficiaries, totaling 3,973 services with total Medicare billing of $225,816. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Lancaster, OH
- Active Since 03/28/2012
- Last Updated 09/08/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1053687525
Products in Payments
- Resolute (Device) $7,417
- CoreValve Evolut (Device) $1,886
- XARELTO (Drug) $561.66
- Coronary Orbital Atherectomy System (Device) $188.98
- AVVIGO Guidance System (Device) $115.22
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $111.67
- WATCHMAN Access System (Device) $78.69
- Stingray (Device) $77.43
- ENTRESTO (Drug) $70.29
- GIAPREZA (Drug) $58.47
- NEXLETOL (Drug) $47.23
- BRILINTA (Drug) $41.84
- FARXIGA (Drug) $41.31
- LEQVIO (Drug) $37.92
- Repatha (Biological) $37.37
- ELIQUIS (Drug) $33.60
- CARDIOMEMS (Device) $26.58
- JARDIANCE (Drug) $25.91
- (CK4) MCOT (Device) $24.53
- CardioMEMS HF System (Device) $20.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lancaster
Dr. Choudhary Chahal, Md, MD
Cardiovascular Disease — Payments: $69,075
Cardiovascular Disease $69,075
Matthew Bernabei, M.d, M.D
Cardiovascular Disease — Payments: $66,222
Cardiovascular Disease $66,222
Dr. Chinmay Patel, Md, MD
Cardiovascular Disease — Payments: $49,665
Cardiovascular Disease $49,665
Dr. Shantanu Sinha, M.d, M.D
Cardiovascular Disease — Payments: $21,979
Cardiovascular Disease $21,979
Dr. John Lazarus, Md, MD
Cardiovascular Disease — Payments: $18,852
Cardiovascular Disease $18,852
Dr. Deepak Shah, M.d, M.D
Cardiovascular Disease — Payments: $17,618
Cardiovascular Disease $17,618